Hoechst reports net profit of Rs 239 m - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Hoechst reports net profit of Rs 239 m

Mar 7, 2001

Hoechst Marion Roussel (HMR) has reported a net profit of Rs 239 m in the nine month ended December 31, 2000. The company reported a net sales of Rs 3.8 bn during the same period.

(Rs m) FY01
Net sales 3,797
Other Income 57
Expenditure 3,234
Operating Profit (EBDIT) 563
Operating Profit Margin (%) 14.8%
Interest 28
Depreciation 90
Profit before Tax 502
Exceptional item 149
Tax 114
Profit after Tax/(Loss) 239
Net profit margin (%) 6.3%
No. of Shares (eoy) (m) 23.0
Earnings per share* 13.9
Current P/e ratio 35.1
HMR is a 51% subsidiary of the $ 14.6 bn Aventis (formed with the merger of HMR AG and Rhone Poulenc). The company has been one of the respected multinational pharmaceutical companies operating in India being the fourth largest player in the domestic market with strong products and a diversified product mix. The company’s brands such as Combiflam, Daonil, Avil, Soframycin, Baralgan–M and Novalgin are household names.

Hoechst has changed its financial year from April-March to January-December. Hence its nine month results are not comparable with the figures of the previous financial year ended March 2000. In FY00, Hoechst had reported a net profit of Rs 275 m, on the back of net sales of Rs 4.8 bn.

The company had restructured its operations after the merger with Roussel. It sold two of its plants in high cost Mumbai and shifted to relatively low cost areas such as Goa (formulations plant) and Ankleshwar (bulk drugs production). The other income includes the proceeds from the sale of one of the plants in Mumbai. Besides, it also sold of its tailend brands such as Omnatax and Haemaccel to Nicholas Piramal last year.

The exceptional items include income from sale of land and surrender of tenancy rights. It also includes ammortisation expenses for VRS, and marketing and technical rights.

At the current price of Rs 486 the stock trades at a P/e multiple of 35 times its annualised nine month FY01 earnings.

Equitymaster requests your view! Post a comment on "Hoechst reports net profit of Rs 239 m". Click here!


More Views on News

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Sep 24, 2020 (Close)


  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks